Reckitt Benckiser Group plcLSE: RKT

Reckitt Benckiser Group: Completion of Russia Hygiene Business Divestment

· Issued by Reckitt Benckiser Group plc via RNS

Summary by 6ix AI

Reckitt Benckiser Group plc (Reckitt), a consumer health and hygiene company whose brands include Dettol, Durex and Lysol, has completed the divestment of its Russia Hygiene business to Arnest Management LLC after receiving all required approvals. The deal was first announced on July 24, 2026.

Key details

  • The Russia Hygiene business will now be excluded from Reckitt's Like-for-Like (LFL) Net Revenue growth percentages, a comparable revenue growth measure, in line with its published Alternative Performance Measure (non-standard financial measure) policies for disposals completed during the year.
  • Restated LFL Net Revenue growth for the third quarter of 2026: Emerging Markets 9.8%, Core Reckitt 3.9%, Core Reckitt + MJN 3.8%.
  • Restated LFL Net Revenue growth for 2026 year to date through the third quarter: Emerging Markets 10.2%, Core Reckitt 3.5%, Core Reckitt + MJN 3.4%.
  • Reckitt does not expect the divestment to have any material impact on delivery of its Group Adjusted Operating Profit or Adjusted EPS (earnings per share) in 2026.

6ix AI wrote this summary from the release below and checked it against the release.

Reckitt Benckiser Group PLC
12 November 2026

P1#yIS1

12 November 2026

Completion of Russia Hygiene business divestment

Further to its announcement of 24 July 2026, Reckitt Benckiser Group plc (“Reckitt”) (LSE:RKT) announces that it has completed the divestment of its Russia Hygiene business to Arnest Management LLC following receipt of all required approvals.

ENDS

1 The Russia Hygiene business will now be excluded from Reckitt's Like-for-Like (LFL) Net Revenue growth percentages, in line with the Group's published Alternative Performance Measure (APM) policies for disposals completed during the year.

2 Following the exclusion of the Russia Hygiene business from LFL Net Revenue, the restated LFL Net Revenue growth is: Q3 2026 Emerging Markets 9.8%, Core Reckitt 3.9%, Core Reckitt + MJN 3.8%; Q3 YTD 2026 Emerging Markets 10.2%, Core Reckitt 3.5%, Core Reckitt + MJN 3.4%.

3 The divestment is not expected to have any material impact on the delivery of Reckitt’s Group Adjusted Operating Profit or Adjusted EPS in 2026.

For enquiries contact:

Investors:

Nick Ashworth

+44 (0)7408 812350

Jon Bone

+44 (0)7408 811493

Media:

Richard Farnsworth

+44 (0)7734 776317

Will Hill

+44 (0)7503 442453

About Reckitt

Reckitt* is a world-class consumer health and hygiene company on a mission to deliver better health in more hands, every day. Founded in 1840 in the United Kingdom, Reckitt is home to some of the world’s most trusted and recognised brands across Germ Protection, Household Care, Intimate Wellness and Self Care, including Dettol, Durex, Finish, Gaviscon, Harpic, Lysol, Mucinex, Nurofen, Strepsils, Vanish and Veet.

Operating in more than 80 countries, Reckitt sells approximately 30 million products every day and employs around 36,000 people worldwide. Through trusted brands, science-led innovation and deep consumer understanding, Reckitt helps make health, hygiene and wellbeing more accessible for millions of people while creating sustainable value for consumers, customers, communities and shareholders.

For more information, visit www.reckitt.com.

*Reckitt is the trading name of the Reckitt Benckiser group of companies

IMPORTANT NOTICES

No statement in this announcement is intended as a profit forecast and no statement in this announcement should be interpreted to mean that the future earnings per share, profits, margins or cash flows of Reckitt following the transaction will necessarily match or be greater than the historical published earnings per share, profits, margins or cash flows of Reckitt.

This announcement may include statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements may be identified by the use of forward-looking terminology, including the terms "believes", "estimates", "plans", "projects", "anticipates", "expects", "intends", "may", "will" or "should" or, in each case, their negative or other variations or comparable terminology, or by discussions of strategy, plans, objectives, goals, future events or intentions. Forward-looking statements may and often do differ materially from actual results. Any forward-looking statements reflect Reckitt's current view with respect to future events and are subject to risks relating to future events and other risks, uncertainties and assumptions including relating to Reckitt's business, results of operations, financial position, liquidity, prospects, growth and strategies. In light of these risks, uncertainties and assumptions, the events described in the forward-looking statement in this announcement may not occur. Forward looking statements speak only as of the date they are made. Except as may be required by law or regulation, Reckitt undertakes no obligation to update any of its forward-looking statements.

Certain figures in this announcement have been subject to rounding.

This announcement does not constitute and should not be construed as, an offer to purchase or sell or issue securities, or otherwise constitute an inducement, invitation, commitment, solicitation or recommendation to any person to purchase, subscribe for, or otherwise acquire securities in Reckitt, or constitute an inducement to enter into any investment activity in any jurisdiction. Nothing contained in this announcement is intended to, nor shall it, form the basis of, or be relied on in connection with, any contract or commitment whatsoever and, in particular, must not be used in making any investment decision.

The distribution, publication, release or presentation of this announcement, in whole or in part, to or from certain jurisdictions may be restricted or prohibited by law or regulation. Recipients of this announcement are required to inform themselves of, and comply with, all restrictions or prohibitions in such jurisdictions. Any failure to comply with applicable requirements may constitute a violation of the laws and/or regulations of such jurisdictions.

Legal Entity Identifier number: 5493003JFSMOJG48V108

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

Reckitt Benckiser Group plc on 6ix

Story so far

Earlier from Reckitt Benckiser

All Reckitt Benckiser news releases